Brand: ALYFTREK. API: vanzacaftor, tezacaftor, and deutivacaftor tablets is used to treat cystic fibrosis (CF).
Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is a once-daily prescription tablet used to treat cystic fibrosis (CF) in adults and children aged 6 years and older.
| Brand Name: | ALYFTREK – On Request |
| Generic Name: | vanzacaftor, tezacaftor, and deutivacaftor tablets |
| Strength: | Tablets:
|
| Manufacturer: | Vertex Pharmaceuticals |
| Approved By: | EMA, USFDA |
| Get access to medicines: | In India |
| Price: | On Request |
See full prescribing information for ALYFTREK: Patient Information
Get access ALYFTREK to treat cystic fibrosis (CF) on a Named Patient Import Basis.
IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to ALYFTREK (vanzacaftor, tezacaftor, and deutivacaftor tablets) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).
For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.
